Abstract
Objective: To investigate if a hospital-initiated home-based rebozo intervention performed by the pregnant woman and her partner before external cephalic version (ECV) would increase the rate of cephalic presentations at birth. Design: A multicentre randomised controlled trial. Setting: Three university hospitals in Copenhagen, Denmark. Population: Pregnant women with a breech or transverse presentation at 35 weeks or more of gestation eligible for ECV. Methods: We compared rebozo before ECV with ECV alone. The randomisation was computer-generated in blocks and stratified by parity. The woman and her partner were instructed in the technique by a project midwife and performed the technique at home three times daily for 3–5 days before the scheduled ECV. Analyses were by intention-to-treat. Main outcome measure: The number of cephalic presentations at the time of birth. Odds ratios (OR) and 95% confidence intervals (CI) were calculated. Results: A total of 372 women were randomly assigned (1:1) to either rebozo intervention (n = 187) or control (n = 185). At birth, 95 (51%) in the intervention group versus 112 (62%) in the control group had a fetus in cephalic presentation (OR 0.61; 95% CI 0.40–0.95). No adverse events were observed in relation to the intervention. Conclusions: In breech or transverse presentation, home-based rebozo exercise before ECV lowered the overall rate of cephalic presentation at birth. Tweetable abstract: Home-based rebozo for breech presentation before external version reduces the rate of cephalic presentation at birth.
Originalsprog | Engelsk |
---|---|
Tidsskrift | BJOG: An International Journal of Obstetrics and Gynaecology |
Vol/bind | 129 |
Udgave nummer | 10 |
Sider (fra-til) | 1666-1675 |
Antal sider | 10 |
ISSN | 1470-0328 |
DOI | |
Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:The study was supported by intramural grants from Copenhagen University Hospital at Hvidovre, the Aase & Ejnar Danielsen Foundation, and the Danish Association of Midwives. No patients were involved in the design or development of the trial. No core outcome sets were used in this study.
Publisher Copyright:
© 2022 John Wiley & Sons Ltd.